Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It is well known that steam onion have benefit effects on controlling the blood sugar, triacylglycerol (TG) and total cholesterol (TC). In this study, the jeju steam onion examined whether it has beneficial effects on reducing body fat of overweight or obesity subjects.
A randomized, double-blind, placebo-controlled clinical trial was conducted to verify the effects of jeju steam onion. Fifty-six healthy male and female subjects aged 20-65 years with normal body weight [25.0 kg/㎡ ≤ body mass index (BMI) < 30.0 kg/㎡] were recruited. The basic framework of the present study was based on a previous study. A 12-week (at each visit; screening, 6-week, 12-week), placebo-controlled, randomized study was conducted with overweight subjects (25.0 kg/㎡ ≤ BMI < 30 kg/㎡). Subjects participants were divided into two group: either Jeju steaming onion or matching placebo (the baked barley powder). Randomization was achieved by computer generated block randomization (placebo : test = 1 : 1).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| baked barley powder consumption | Placebo Comparator | Subjects randomized to the placebo group received one tablet containing baked barley powder per day (900 mg/day). placebo group consumed one capsules, three times daily before meals, for a total of three capsules consumed per day. |
|
| jeju steam onion powder consumption | Experimental | Subjects randomized to the test group received one tablet containing jeju steam onion powder per day (900 mg/day). placebo group consumed one capsules, three times daily before meals, for a total of three capsules consumed per day. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| baked barley powder | Dietary Supplement | The baked barley was consumed one capsules, three times daily before meals, for a total of three capsules consumed per day.The baked barley powder capsule had approximately 900 mg/day, 336 mg of baked barley and 564 mg of nondigestible maltodextrin. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline fat mass at 12-week. | The body composition of the study participants was measured via dual-energy X-ray absorptiometry (DEXA) to determine | at baseline and 12-week follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline fat percentage at 12-week. | The body composition of the study participants was measured via dual-energy X-ray absorptiometry (DEXA) to determine | at baseline and 12-week follow-up |
| Change from baseline lean body mass at 12-week. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline weight at 12-week. | Briefly, all data were acquired at baseline and week 12. body weight (kg; Inbody370, Biospace Co., Ltd Korea) was measured. | at baseline and 12-week follow-up |
| Change from baseline body mass index at 12-week. |
Inclusion Criteria:
overweight(WHO) subjects [25.0 kg/㎡ ≤ body mass index (BMI) < 30 kg/㎡]
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University. | Seoul | 03722 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31368861 | Derived | Jeong S, Chae J, Lee G, Shin G, Kwon YI, Oh JB, Shin DY, Lee JH. Effect of Steamed Onion (ONIRO) Consumption on Body Fat and Metabolic Profiles in Overweight Subjects: A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Am Coll Nutr. 2020 Mar-Apr;39(3):206-215. doi: 10.1080/07315724.2019.1635052. Epub 2019 Aug 1. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D050177 | Overweight |
| D003920 | Diabetes Mellitus |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| jeju steam onion | Dietary Supplement | The jeju steam onion was consumed one capsules, three times daily before meals, for a total of three capsules consumed per day.The jeju steam onion capsule had approximately 900 mg/day, 336 mg of jeju steam onion powder and 564 mg of nondigestible maltodextrin. |
|
The body composition of the study participants was measured via dual-energy X-ray absorptiometry (DEXA) to determine
| at baseline and 12-week follow-up |
| Change from baseline whole fat area of L1 and L4 at 12-week. | The abdominal fat distribution was measured at L1 and L4 by computed tomography (CT) | at baseline and 12-week follow-up |
| Change from baseline visceral fat area of L1 and L4 at 12-week. | The abdominal fat distribution was measured at L1 and L4 by computed tomography (CT) | at baseline and 12-week follow-up |
| Change from baseline subcutaneous fat area of L1 and L4 at 12-week. | The abdominal fat distribution was measured at L1 and L4 by computed tomography (CT) | at baseline and 12-week follow-up |
| Change from baseline visceral/subcutaneous fat area ratio of L1 and L4 at 12-week. | The abdominal fat distribution was measured at L1 and L4 by computed tomography (CT) | at baseline and 12-week follow-up |
Briefly, all data were acquired at baseline and week 12. BMI was calculated in units of kilogram per square meter (kg/㎡).
| at baseline and 12-week follow-up |
| Change from baseline height(cm) at 12-week. | Briefly, all data were acquired at baseline and week 12. height(cm) was measured. | at baseline and 12-week follow-up |
| Change from baseline waist circumference(cm) at 12-week. | Briefly, all data were acquired at baseline and week 12. waist circumference(cm) was measured. | at baseline and 12-week follow-up |
| Change from baseline blood pressure (BP; mmHg) at 12-week. | Briefly, all data were acquired at baseline and week 12. blood pressure (BP; mmHg) was measured. | at baseline and 12-week follow-up |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D004700 | Endocrine System Diseases |